Phase 3 TRIUMPH trial results The Phase 3 TRIUMPH-4 trial, announced in late 2025, confirmed and even improved on the Phase 2 numbers
This article examines the clinical evidence, safety considerations, dosing strategies, and patient selection criteria for using tirzepatide and metformin together
Ralph DJ, Hughes T, Lees WR, Pryor JP
Because of this reason and challenges in dose regulation through patches, the FDA has not approved transdermal patches for GLP-1 drugs yet
Compounded semaglutide is $189 monthly month-to-month, or from $149/mo on the 6-month plan through licensed 503A pharmacies
Past efforts to intervene in the disease by drugging targets including metabolism, mitochondria, secretases, steroid hormones, and cholesterol had yielded one disappointment after another